ATE407665T1 - Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken - Google Patents
Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem druckenInfo
- Publication number
- ATE407665T1 ATE407665T1 AT03747680T AT03747680T ATE407665T1 AT E407665 T1 ATE407665 T1 AT E407665T1 AT 03747680 T AT03747680 T AT 03747680T AT 03747680 T AT03747680 T AT 03747680T AT E407665 T1 ATE407665 T1 AT E407665T1
- Authority
- AT
- Austria
- Prior art keywords
- shell
- release
- dosage form
- core
- diffusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
- B29C64/10—Processes of additive manufacturing
- B29C64/141—Processes of additive manufacturing using only solid materials
- B29C64/153—Processes of additive manufacturing using only solid materials using layers of powder being selectively joined, e.g. by selective laser sintering or melting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37844902P | 2002-05-06 | 2002-05-06 | |
US42509402P | 2002-11-08 | 2002-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE407665T1 true ATE407665T1 (de) | 2008-09-15 |
Family
ID=29406838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03747680T ATE407665T1 (de) | 2002-05-06 | 2003-05-06 | Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken |
Country Status (9)
Country | Link |
---|---|
US (2) | US8088415B2 (de) |
EP (1) | EP1503741B1 (de) |
JP (1) | JP5041663B2 (de) |
AT (1) | ATE407665T1 (de) |
AU (1) | AU2003232078A1 (de) |
CA (1) | CA2483028C (de) |
DE (1) | DE60323482D1 (de) |
ES (1) | ES2316791T3 (de) |
WO (1) | WO2003092633A2 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE407665T1 (de) | 2002-05-06 | 2008-09-15 | Massachusetts Inst Technology | Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken |
ATE544447T1 (de) * | 2003-09-26 | 2012-02-15 | Alza Corp | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung |
US20060002594A1 (en) * | 2004-06-09 | 2006-01-05 | Clarke Allan J | Method for producing a pharmaceutical product |
TWI428271B (zh) * | 2004-06-09 | 2014-03-01 | Smithkline Beecham Corp | 生產藥物之裝置及方法 |
US8101244B2 (en) * | 2004-06-09 | 2012-01-24 | Smithkline Beecham Corporation | Apparatus and method for producing or processing a product or sample |
JPWO2006004069A1 (ja) * | 2004-07-01 | 2008-04-24 | 日本碍子株式会社 | 微小カプセルおよびその製造方法 |
EP2131817A2 (de) * | 2007-03-09 | 2009-12-16 | Synthon B.V. | Pharmazeutische zusammensetzung von quetiapinfumarat |
EP2227226B1 (de) * | 2007-12-21 | 2016-10-26 | Johnson & Johnson Consumer Inc. | Herstellung einer tablette |
CN101716162B (zh) * | 2009-11-26 | 2012-11-14 | 扬州中宝制药有限公司 | 一种氨茶碱缓释胶囊及其制备方法 |
US8251837B2 (en) * | 2010-08-11 | 2012-08-28 | Nike, Inc. | Floating golf ball |
EP2651399A2 (de) | 2010-12-13 | 2013-10-23 | Purdue Pharma LP | Retard-darreichungsformen |
US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
KR101835288B1 (ko) | 2012-09-05 | 2018-03-06 | 아프레시아 파마슈티칼스 컴퍼니 | 3차원 인쇄 시스템 및 장비 어셈블리 |
US8888480B2 (en) | 2012-09-05 | 2014-11-18 | Aprecia Pharmaceuticals Company | Three-dimensional printing system and equipment assembly |
US20140099351A1 (en) * | 2012-10-04 | 2014-04-10 | Axxia Pharmaceuticals, Llc | Process for making controlled release medical implant products |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
CN109908355B (zh) | 2013-03-15 | 2022-11-15 | 阿普雷奇亚制药有限责任公司 | 包含左乙拉西坦的快速分散剂型 |
CN105579161A (zh) | 2013-08-16 | 2016-05-11 | 艾克斯温有限责任公司 | 三维打印的金属铸造模具和其制造方法 |
EP3057729A4 (de) | 2013-10-17 | 2017-10-18 | The Exone Company | Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon |
EP2875933B1 (de) * | 2013-11-25 | 2019-04-03 | MTU Aero Engines GmbH | Dokumentation generativer Herstellungsverfahren |
US9649279B2 (en) | 2013-12-16 | 2017-05-16 | Massachusetts Institute Of Technology | Fortified micronutrient salt formulations |
EP3763383A1 (de) * | 2013-12-16 | 2021-01-13 | Massachusetts Institute Of Technology | Mikrogeformte oder 3d-gedruckte impfstoffformulierungen mit pulsierender freisetzung |
ES2745763T3 (es) | 2013-12-23 | 2020-03-03 | The Exone Co | Métodos y sistemas para la impresión en tres dimensiones utilizando múltiples fluidos aglutinantes |
EP3086922B1 (de) | 2013-12-23 | 2022-03-09 | The Exone Company | Verfahren zum dreidimensionalen drucken unter verwendung eines mehrkomponentigen konstruktionspulvers |
IL232696B (en) * | 2014-05-19 | 2018-08-30 | Technion Res & Dev Foundation | Compound and method for detecting molecules of interest |
EP3148730A1 (de) | 2014-05-29 | 2017-04-05 | The Exone Company | Verfahren zur herstellung von superlegierungsartikeln auf nickelbasis durch dreidimensionales drucken |
WO2016011098A2 (en) | 2014-07-17 | 2016-01-21 | The Exone Company | Methods and apparatuses for curing three-dimensional printed articles |
CN114670437A (zh) * | 2014-09-08 | 2022-06-28 | 中央兰开夏大学 | 固体剂型生产 |
US9844930B2 (en) | 2014-11-05 | 2017-12-19 | Xerox Corporation | 3D printing of digestible shells for medicaments |
CN107206746A (zh) | 2014-12-03 | 2017-09-26 | 艾克斯温有限责任公司 | 通过三维打印制造致密碳制品的方法 |
CN108721242B (zh) * | 2015-06-03 | 2021-03-02 | 南京三迭纪医药科技有限公司 | 药品剂型及其使用 |
KR20180014778A (ko) | 2015-06-03 | 2018-02-09 | 트리아스텍 인코포레이티드 | 제형 및 이의 용도 |
US20180214383A1 (en) * | 2015-07-16 | 2018-08-02 | National University Of Singapore | Printing drug tablets with fully customizable release profiles for personalized medicine |
CN116423825A (zh) | 2015-08-21 | 2023-07-14 | 阿普雷奇亚制药有限责任公司 | 三维打印系统和设备组件 |
GB201519128D0 (en) | 2015-10-29 | 2015-12-16 | Univ Central Lancashire | Solid forms and methods of preparing the same |
CA3023278C (en) | 2016-05-05 | 2019-04-30 | Triastek, Inc. | Controlled release dosage form |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
GB201612853D0 (en) | 2016-07-25 | 2016-09-07 | Univ Central Lancashire | Solid dosage form production |
EP3321002A1 (de) * | 2016-11-15 | 2018-05-16 | Höganäs AB | Ausgangsmaterial für generatives fertigungsverfahren, generatives fertigungsverfahren damit und daraus erhaltener artikel |
DE102017200773A1 (de) * | 2017-01-18 | 2018-07-19 | Eos Gmbh Electro Optical Systems | Verfahren zum Nachbehandeln und Nachbehandlungssytem |
KR20230157528A (ko) * | 2017-01-26 | 2023-11-16 | 트리아스텍 인코포레이티드 | 특정 위장 부위에서의 제어 방출의 투여 형태 |
US10369557B2 (en) | 2017-04-12 | 2019-08-06 | International Business Machines Corporation | Three-dimensional printed objects for chemical reaction control |
US20210213678A1 (en) * | 2017-04-28 | 2021-07-15 | Hewlett-Packard Development Company, L.P. | Producing diffusion-controlled release devices |
WO2019025869A1 (en) * | 2017-07-31 | 2019-02-07 | Teva Pharmaceutical Industries Limited | GALENIC FORMS WITH CONTROLLED RELEASE MANUFACTURED IN ADDITIVE MANNER |
US11642841B2 (en) | 2017-10-13 | 2023-05-09 | Ut-Battelle, Llc | Indirect additive manufacturing process |
WO2019137200A1 (en) | 2018-01-09 | 2019-07-18 | Triastek, Inc. | Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant |
US10350822B1 (en) | 2018-01-09 | 2019-07-16 | Triastek Inc. | Dosage forms with desired release profiles and methods of designing and making thereof |
US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
DE102018107585B3 (de) * | 2018-03-29 | 2019-03-28 | Universität Rostock | Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen |
WO2019199328A1 (en) * | 2018-04-13 | 2019-10-17 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
CN108939162B (zh) * | 2018-07-10 | 2021-11-19 | 上海理工大学 | 一种介孔生物玻璃/海藻酸钠-海藻酸钠分层骨组织工程支架的制备方法 |
GB201813186D0 (en) | 2018-08-13 | 2018-09-26 | Univ Central Lancashire | Solid dosage from production |
WO2020053319A1 (en) * | 2018-09-14 | 2020-03-19 | Merck Patent Gmbh | Process for the preparation of a coated solid pharmaceutical dosage form |
ES2930199T3 (es) | 2018-10-15 | 2022-12-07 | Aprecia Pharmaceuticals LLC | Método y sistema para formar una forma farmacéutica dentro de un envase |
US11254617B2 (en) | 2019-01-09 | 2022-02-22 | Ut-Battelle, Llc | Indirect additive manufacturing process using amine-containing adhesive polymers |
US12103229B2 (en) * | 2019-03-15 | 2024-10-01 | Ricoh Company, Ltd. | Jettable temporary binders to create removable support materials |
US11724486B2 (en) | 2019-07-09 | 2023-08-15 | Kyndryl, Inc. | Printing customized medication based on current user data and medical records of the user |
AU2020329531A1 (en) * | 2019-08-14 | 2022-03-31 | Merck Patent Gmbh | Method for additive manufacture of a product, manufacturing device and solid pharmaceutical dosage form |
GB201913972D0 (en) | 2019-09-27 | 2019-11-13 | Univ Ulster | Pharmaceutical Delivery Device and method of manufacture |
ES2828509B2 (es) | 2019-11-26 | 2022-03-09 | Fund Idonial | Composicion para la impresion 3d de farmacos semisolidos |
EP3871859A1 (de) * | 2020-02-26 | 2021-09-01 | Hewlett-Packard Development Company, L.P. | Dreidimensionales drucken |
WO2021176361A1 (en) * | 2020-03-02 | 2021-09-10 | Craft Health Pte Ltd | Method of manufacturing oral dosage forms for extended drug release |
CN116018131A (zh) | 2020-06-26 | 2023-04-25 | 阿普雷奇亚制药有限责任公司 | 具有内腔的快速口腔分散片剂 |
EP4238556A4 (de) | 2020-10-30 | 2024-09-25 | Triastek Inc | Gastroretentive pharmazeutische darreichungsform |
CN112940690B (zh) * | 2021-02-05 | 2021-11-02 | 中国科学院苏州纳米技术与纳米仿生研究所南昌研究院 | 一种具有豆荚结构的相变储能材料及其制备方法与应用 |
WO2024108084A1 (en) * | 2022-11-18 | 2024-05-23 | Aprecia Pharmaceuticals LLC | Functionally-dividable orodispersive dosage form |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US948297A (en) * | 1909-07-24 | 1910-02-01 | John A Stone | Corn-husker. |
US986148A (en) * | 1910-05-09 | 1911-03-07 | Hoechst Ag | Derivative of oxyarylarsinic acids and process of making same. |
ZA822995B (en) * | 1981-05-21 | 1983-12-28 | Wyeth John & Brother Ltd | Slow release pharmaceutical composition |
IE59287B1 (en) * | 1984-02-10 | 1994-02-09 | Benzon Pharma As | Diffusion coated multiple-units dosage form |
US4810502A (en) * | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5204055A (en) | 1989-12-08 | 1993-04-20 | Massachusetts Institute Of Technology | Three-dimensional printing techniques |
NZ286242A (en) * | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
US5490882A (en) | 1992-11-30 | 1996-02-13 | Massachusetts Institute Of Technology | Process for removing loose powder particles from interior passages of a body |
US5775402A (en) | 1995-10-31 | 1998-07-07 | Massachusetts Institute Of Technology | Enhancement of thermal properties of tooling made by solid free form fabrication techniques |
US5490962A (en) | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US6280771B1 (en) | 1997-02-20 | 2001-08-28 | Therics, Inc. | Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof |
ATE292456T1 (de) * | 1996-09-13 | 2005-04-15 | Shionogi & Co | Zubereitung mit verlängerter freisetzung unter verwendung einer thermischen umwandlung sowie verfahren zu deren herstellung |
WO1998036738A1 (en) | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
US5934343A (en) | 1997-03-31 | 1999-08-10 | Therics, Inc | Method for dispensing of powders |
US6213168B1 (en) | 1997-03-31 | 2001-04-10 | Therics, Inc. | Apparatus and method for dispensing of powders |
US6547994B1 (en) | 1998-11-13 | 2003-04-15 | Therics, Inc. | Rapid prototyping and manufacturing process |
US6485746B1 (en) * | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
DE19961897A1 (de) * | 1999-12-20 | 2001-06-28 | Basf Ag | Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen |
DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
WO2001087272A2 (en) * | 2000-05-18 | 2001-11-22 | Therics, Inc. | Encapsulating a toxic core within a non-toxic region in an oral dosage form |
WO2002038280A2 (en) * | 2000-11-10 | 2002-05-16 | Therics, Inc. | A wetting-resistant nozzle for dispensing small volumes of liquid and a method for manufacturing a wetting-resistant nozzle |
ATE407665T1 (de) | 2002-05-06 | 2008-09-15 | Massachusetts Inst Technology | Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken |
US20050015728A1 (en) * | 2003-07-17 | 2005-01-20 | International Business Machines Corporation | Method, system, and program product for customizing a user interface |
-
2003
- 2003-05-06 AT AT03747680T patent/ATE407665T1/de not_active IP Right Cessation
- 2003-05-06 JP JP2004500818A patent/JP5041663B2/ja not_active Expired - Lifetime
- 2003-05-06 US US10/431,353 patent/US8088415B2/en active Active
- 2003-05-06 EP EP03747680A patent/EP1503741B1/de not_active Expired - Lifetime
- 2003-05-06 DE DE60323482T patent/DE60323482D1/de not_active Expired - Lifetime
- 2003-05-06 ES ES03747680T patent/ES2316791T3/es not_active Expired - Lifetime
- 2003-05-06 WO PCT/US2003/014376 patent/WO2003092633A2/en active Application Filing
- 2003-05-06 AU AU2003232078A patent/AU2003232078A1/en not_active Abandoned
- 2003-05-06 CA CA2483028A patent/CA2483028C/en not_active Expired - Lifetime
-
2011
- 2011-11-29 US US13/306,393 patent/US8465777B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2483028A1 (en) | 2003-11-13 |
DE60323482D1 (de) | 2008-10-23 |
EP1503741B1 (de) | 2008-09-10 |
WO2003092633A2 (en) | 2003-11-13 |
US8465777B2 (en) | 2013-06-18 |
EP1503741A2 (de) | 2005-02-09 |
JP2005524702A (ja) | 2005-08-18 |
US8088415B2 (en) | 2012-01-03 |
ES2316791T3 (es) | 2009-04-16 |
CA2483028C (en) | 2011-04-05 |
US20120177696A1 (en) | 2012-07-12 |
US20040005360A1 (en) | 2004-01-08 |
WO2003092633A3 (en) | 2004-04-08 |
AU2003232078A1 (en) | 2003-11-17 |
JP5041663B2 (ja) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE407665T1 (de) | Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken | |
BRPI0912411B8 (pt) | uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune | |
MX348282B (es) | Formulaciones farmaceuticas de liberacion controlada de nitazoxanida. | |
WO2003084539A3 (en) | New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors | |
MY149601A (en) | Masking the taste of powders | |
EP1523994A4 (de) | Medizinische zusammensetzung zur regulierung der freisetzung und verfahren zu deren herstellung | |
MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
PL367277A1 (en) | Methods of making sustained release formulations of oxymorphone related applications | |
WO2005115530A3 (en) | Seizure therapy method and apparatus | |
HUP0400782A2 (hu) | Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények | |
IL192374A0 (en) | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol | |
MX2008011978A (es) | Tratamiento del cancer de seno negativo al triple receptor. | |
DE502004005154D1 (de) | Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform | |
TW200738228A (en) | Neramexane modified release matrix tablet | |
IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
NO20071044L (no) | Doseformer med enteraltbelagte tablettkjerner | |
EP3981399A4 (de) | Orale feste tablette mit einem tyrosinkinaseinhibitor und herstellungsverfahren dafür | |
DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
WO2021034958A3 (en) | Materials for delivery of tetherable proteins in bone implants | |
UA91694C2 (ru) | Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций | |
MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. | |
WO2009024838A3 (en) | Impression and model components | |
TW200621312A (en) | Oral solid dosage forms containing a low dose of estradiol | |
RS20050835A (en) | Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions | |
ECSP045232A (es) | Forma de dosificación oral, procedimiento para prepararla y uso de una base débil farmacéuticamente aceptable o una sal o solvato farmacéuticamente aceptable de la misma para preparar dicha forma de dosificación oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |